Claudia Filozof, MD, PhD, Vice President, Liver Theraputic Area
- Board-certified in nutrition in metabolism
- 20+ years of experience in clinical research in the pharma and CRO businesses
- Leads development programs on obesity and diabetes and has been fully dedicated to NAFLD/NASH and cholestatic liver diseases since 2011
- Member of the Liver and PSC Forum, AASLD steatohepatitis working group and EASL NAFLD group
- Author of multiple manuscripts including six recent review papers about clinical development in NASH and adaptive design studies